HD204

· Prestige Biopharma Limited

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for HD204, covering 2024-11-19 to 2026-06-17. Get the full timeline:

Most recent: Clinical Trial Results: To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects [Phase 1]

See pricing